Edgewise Therapeutics Inc (EWTX)
32.20
+0.22
(+0.69%)
USD |
NASDAQ |
Nov 22, 16:00
33.00
+0.80
(+2.48%)
After-Hours: 20:00
Edgewise Therapeutics Free Cash Flow: -110.10M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -110.10M |
| June 30, 2024 | -104.72M |
| March 31, 2024 | -99.39M |
| December 31, 2023 | -97.69M |
| September 30, 2023 | -85.85M |
| June 30, 2023 | -76.63M |
| March 31, 2023 | -72.43M |
| December 31, 2022 | -58.18M |
| Date | Value |
|---|---|
| September 30, 2022 | -52.53M |
| June 30, 2022 | -47.95M |
| March 31, 2022 | -41.00M |
| December 31, 2021 | -34.18M |
| September 30, 2021 | -29.32M |
| June 30, 2021 | -23.88M |
| March 31, 2021 | -18.21M |
| December 31, 2020 | -14.84M |
Free Cash Flow Range, Past 5 Years
-110.10M
Minimum
Sep 2024
-14.84M
Maximum
Dec 2020
-60.43M
Average
-55.36M
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 221.79M |
| Cytokinetics Inc | -407.05M |
| Vanda Pharmaceuticals Inc | -18.20M |
| Vertex Pharmaceuticals Inc | -1.352B |
| Sarepta Therapeutics Inc | -480.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.37M |
| Cash from Investing (Quarterly) | 25.36M |
| Cash from Financing (Quarterly) | 3.333M |
| Free Cash Flow Per Share (Quarterly) | -0.2973 |
| Free Cash Flow Yield | -4.03% |